These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease. Dean M; Sung VW Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277 [TBL] [Abstract][Full Text] [Related]
13. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Guay DR Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622 [TBL] [Abstract][Full Text] [Related]
16. Valbenazine (Ingrezza) for tardive dyskinesia. Med Lett Drugs Ther; 2017 May; 59(1521):83-84. PubMed ID: 28520698 [No Abstract] [Full Text] [Related]
17. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Chen JJ; Ondo WG; Dashtipour K; Swope DM Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259 [TBL] [Abstract][Full Text] [Related]
18. Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study. Dorsey ER; Brocht AF; Nichols PE; Darwin KC; Anderson KE; Beck CA; Singh S; Biglan KM; Shoulson I J Huntingtons Dis; 2013; 2(4):509-15. PubMed ID: 25062735 [TBL] [Abstract][Full Text] [Related]
19. Selective Serotonin Reuptake Inhibitors and Tardive Dyskinesia: A Case Report of Escitalopram Use in a Cardiac and Liver Transplant Patient. Fischer A; Connor AT; Machenzie KM; Shaw RJ J Clin Psychopharmacol; 2020; 40(6):626-627. PubMed ID: 33136924 [No Abstract] [Full Text] [Related]
20. Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment. Citrome L; Saklad SR J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32078259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]